Edition:
India

People: Celon Pharma SA (CLNP.WA)

CLNP.WA on Warsaw Stock Exchange

44.30PLN
15 Nov 2019
Change (% chg)

0.50zł (+1.14%)
Prev Close
43.80zł
Open
43.55zł
Day's High
44.90zł
Day's Low
43.55zł
Volume
3,973
Avg. Vol
9,948
52-wk High
51.10zł
52-wk Low
28.25zł

Kaczmarczyk, Krzysztof 

Mr. Krzysztof Robert Kaczmarczyk has served as Independent Member of the Supervisory Board of Celon Pharma S.A. since April 9, 2018. He is Member of the Audit Committee at the Company. In 2011 he graduated from Szkola Glowna Handlowa w Warszawie. He started his career at Deutsche Morgan Greenfell, where in 2002 he served as Analyst Assistant. From 2002 to 2007 he was an Analyst at DB Securities S.A. and from 2008 to 2010 he worked for Grupa TP S.A. From 2010 to 2011 he served at Credit Suisse in Poland. From 2012 to 2015 he was Vice Chairman of the Management Board for Strategy and Development at Emitel. He has been on the Supervisory Board of Action, Arteria, Alta, Braster, BSC Drukarnia Opakowan, Gielda Papierow Wartosciowych, LC Corp, KGHM, Work Service, TIM, Best, Integer, SARE, Magellan, Robyg, InPost, Polimex-Mostostal, Duon, Polish Energy Partners, Graal, Wirtualna Polska, 4fun Media.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --